Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report

Riv Psichiatr. 2014 Jul-Aug;49(4):192-4. doi: 10.1708/1600.17462.

Abstract

We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment- resistant bipolar disorders, both as augmenting agent and as a monotherapy. Moreover, we observed an acute antimanic and sustained mood-stabilizing effect also in "naïve" bipolar type I disorder. Here we report a case history of a young woman suffering from bipolar type II mood disorder, associated with a very severe eating disorder, showing an acute antimanic and a long-term prophylactic effect of memantine on bipolar disorder and comorbid eating disorder.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antimanic Agents / therapeutic use*
  • Bipolar Disorder / classification
  • Bipolar Disorder / complications
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / prevention & control*
  • Feeding and Eating Disorders / complications
  • Female
  • Humans
  • Memantine / therapeutic use*
  • Mood Disorders / classification
  • Mood Disorders / complications
  • Mood Disorders / drug therapy*
  • Mood Disorders / prevention & control*

Substances

  • Antimanic Agents
  • Memantine